Steffen Thomas's most recent trade in Anavex Life Sciences Corporation was a trade of 50,000 Common stock done at an average price of $1.8 . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.76 per share. | 05 Jun 2025 | 50,000 | 55,000 (0%) | 0% | 1.8 | 88,000 | Common stock |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.75 per share. | 05 Jun 2025 | 11,349 | 43,651 (0%) | 0% | 7.8 | 87,955 | Common stock |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Purchase of securities on an exchange or from another person at price $ 4.52 per share. | 15 May 2024 | 5,000 | 5,000 (0%) | 0% | 4.5 | 22,600 | Common Stock |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Anavex Life Sciences Corpo... | Steffen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |